Product Information
PREMPHASE 0.625-5 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $8.6814 per EA under NDC 00046257512. Its NADAC has been published 657 times since Nov 28, 2013.
NDC
00046257512
Classification
Brand
Dosage Form
KIT
Last Updated
1/1/2026
Approval Type
New Drug (NDA)
FDA Application
NDA020527On Market Since
3/1/2012
Price Statistics
The NADAC for PREMPHASE 0.625-5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 156.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.6814 per EA |
|---|---|
| All-time high | $8.6814 (Jun 24, 2026) |
| All-time low | $3.3889 (Nov 28, 2013) |
| 52-week high | $8.6814 |
| 52-week low | $8.4475 |
| Median price | $6.9125 |
| Average price | $6.6785 |
| Largest weekly change | +9.5% (Jun 11, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the conjugated estrogens and medroxyprogesterone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PREMPHASE 0.625-5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PREMPHASE 0.625-5 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $8.6814 per EA (NDC 00046257512), effective Jun 24, 2026.
How has the price of PREMPHASE 0.625-5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PREMPHASE 0.625-5 MG TABLET has risen 156.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREMPHASE 0.625-5 MG TABLET?
Since Nov 28, 2013, the NADAC for PREMPHASE 0.625-5 MG TABLET has ranged from a low of $3.3889 (Nov 28, 2013) to a high of $8.6814 (Jun 24, 2026), with a median of $6.9125 per EA.
Are there cheaper alternatives to PREMPHASE 0.625-5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PREMPHASE 0.625-5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PREMPHASE 0.625-5 MG TABLET?
PREMPHASE 0.625-5 MG TABLET (NDC 00046257512) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification